Company CVAbout Sigachi Industries Ltd 
Sigachi Industries Ltd
Small Cap
Pharmaceuticals & Drugs
Sigachi Industries Limited was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989. To diversify the business activities, name of the Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012. Subsequently, Company was converted from a Private Limited to a Public Limited and consequently, name was changed to 'Sigachi Industries Limited' effective on 19 December, 2019.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 33.34 Cr
Number of Shares
33.34 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-Aug-2024
33.34
33.34
5252190
1
Issued under ESOP Scheme
10-Oct-2023
32.35
32.35
16051900
1
Conversion of Warrants
09-Oct-2023
30.74
30.74
276682500
1
Stock Split
10-Nov-2021
3.07
30.74
7695000
10
Public Issue
10-Nov-2021
3.07
30.74
7695000
10
Public Issue
30-Jul-2021
2.3
23.05
15365000
10
Bonus Issue
21-Nov-2019
76.83
7.68
4609500
10
Bonus Issue
28-Mar-2017
30.73
3.07
73000
10
Preferential basis
31-Mar-2015
3
3.00
331310
10
Preferential basis
04-Oct-2014
26.69
2.67
1387330
10
Scheme of Arrangement
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
20.6639
Mutual Funds
Held by 2 Schemes (0.0%)
FIIs
Held by 7 FIIs (0.21%)
Promoter with highest holding
Rps Industries Private Limited (19.71%)
Highest Public shareholder
Rakesh Yadav (3.21%)
Individual Investors Holdings
40.5%
Board of Directors
Management
Designation
Remuneration
Rabindra Prasad Sinha
Chairman & Wholetime Director
1.5 cr
Chidambarnathan Shanmuganathan
Vice Chairman & Whole Time Dir
1.5 cr
Amit Raj Sinha
Managing Director & CEO
2.21 cr
Sarveswar Reddy Sanivarapu
Independent Non Exe. Director
6.3 lacs
Dhanalakshmi Guntaka
Independent Non Exe. Director
5.7 lacs
Bindu Vinodhan
Independent Non Exe. Director
1.4 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
139 Cr
(Quarterly Results - Dec 2024)
Net Profit:
21 Cr
Pharmaceuticals & Drugs
INR 1,281 Cr (Small Cap)
17.00
33
0.26%
0.19
14.01%
2.61
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
